Notre Dame researcher uses tumor cells to evaluate the effectiveness of current medications Amanda Hummon, Huisking Foundation, Inc. Associate Professor of Chemistry and Biochemistry In recent years researchers have begun to understand that the development of colon cancer, which is the second most common cancer in the United States, can...

Notre Dame researcher explores bacteria beyond the ability of typical hospital setting  Gail Weaver, post-doctoral research associate Each year 332,000 total hip replacements are performed in the United States, according to the Centers for Disease Control and Prevention. Out of those, nearly one percent of patients will get an infection...

Cancer survivor builds tissue bank for Harper Cancer Research Institute Toni Page-Mayberry, tissue bank consent coordinator at the Harper Cancer Research Institute These days, Page-Mayberry funnels that passion into her job as the tissue bank consent coordinator for the Mike and Josie Harper Cancer Research Institute at Notre Dame. Her...

Notre Dame researcher explores the potential of producing mammalian-like proteins with silkworm moths Professor Malcolm Fraser Jr. The availability of medicines in many low- and middle-income countries is undermined by poor medicine supply, insufficient health facilities, and the high cost of medicine, according to the World Health Organization. This includes...

Researchers comparing mouse and macaque brains have found evidence of an evolutionary universal brain structure in mammals that enables comparisons of cortical networks between species. A new study from a researcher at the University of Notre Dame could provide insights into brain disorders such as Alzheimer’s and schizophrenia.

Brian Baker, recently named the Rev. John A. Zahm Professor of Structural Biology, has been appointed to the position of chair of the Department of Chemistry and Biochemistry, effective July 1, 2016.

Alex Perkins, Ph.D., Eck Family Assistant Professor in the Departments of Biological Sciences and Applied and Computational Mathematics and Statistics, and a member of the Eck Institute for Global Health, recently published a study looking at behavior of patients with one of the most common symptoms of disease: fever.  Surprisingly,...

Women in Science Regional Conference Sept. 30 – Oct. 1, 2016 The Association for Women in Science (AWIS) at Notre Dame is hosting the first ever Women in Science Regional Conference on Sep. 30th – Oct 1st. Graduate students will have the opportunity to network with high profile professionals from across the US, attend career development workshops and participate...

When battling cancer, everything is on the table. Radiation therapy. Surgery. Chemo. Advances in nanotechnology have enabled researchers, like Associate Professor Z. Basar Bilgicer, Research Assistant Professor Tanyel Kiziltepe, and their team in the Department of Chemical and Biomolecular Engineering at the University of Notre Dame, to encapsulate cancer-fighting/cancer-killing drugs...

Sharon Stack and Matt Ravosa joined the University of Notre Dame in 2011, coming from positions at the University of Missouri School of Medicine in Columbia, Missouri. Stack is the Ann F. Dunne and Elizabeth Riley Director of the Harper Cancer Research Institute (HCRI) and the Kleiderer-Pezold Professor of Chemistry...

Two Notre Dame graduate students, Nameera Baig and Nur Mustafaoglu, have been awarded the 2016 Berry Family Foundation Graduate Fellowships in Advanced Diagnostics & Therapeutics for their innovative research in tracking and treating disease.   …

Notre Dame’s Harper Cancer Research Institute is trying a different strategy in the fight against the disease: bringing scientists from diverse fields onto a single team. Introducing herself around campus in 2011, biochemist Sharon Stack sought faculty far outside her academic background. She wanted to get a feel for the...

As Richard Taylor completes a three-year term as associate vice president for research in June of this year, he will continue his research on drug discovery for rare genetic diseases, like NGLY1 deficiency, when he and other members of the Warren Family Research Center for Drug Discovery and Development move into the...

Michael Hildreth is appointed the next Associate Dean for Research and Graduate Studies effective July 1, 2016. He replaces Brian Baker, who steps down as associate dean after three years of leadership. Says Hildreth of his new role, “I’m excited and humbled by this opportunity to increase the breadth and...

VeriPAD, a startup created by a multidisciplinary team of City College of New York (CUNY) students and recent graduates in collaboration with University of Notre Dame faculty, was awarded the $25,000 Zahn Innovation Center social impact new venture competition grand prize.

In partnership with the Notre Dame Initiative for Global Development (NDIGD), Professor of Chemistry Marya Lieberman and her research team have received support from VWR , a leading global independent provider of product and service solutions to laboratory and production customers.

At the University of Notre Dame, the Molecular Structure Facility (MSF) analyzes organic or inorganic substances at an atomic level, which allows researchers to learn about the three-dimensional structure and connectivity of the compound they have created. Knowing the molecular make-up of substances oftentimes provides faculty, postdoctoral fellows, and graduate...

The University of Notre Dame’s Harper Cancer Research Institute will hold an open house from 4 to 6:30 p.m. June 28 (Tuesday) in Harper Hall. The event is free and open to the public, and refreshments will be provided.

The Graduate School is pleased to announce its second cohort of the Ethical Leaders in STEM program, a yearlong leadership development opportunity for third- and fourth-year PhD graduate students.

In late 2015, former President Jimmy Carter announced that he was free of the metastatic melanoma that had spread to his liver and brain. In addition to surgery and radiation, Carter was treated with an immunotherapy drug, a new approach in cancer treatment that has a promising outlook.